UK markets closed

Elevance Health, Inc. (0HG8.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
519.15+0.14 (+0.03%)
At close: 06:42PM GMT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.78
52-week change 38.85%
S&P500 52-week change 327.86%
52-week high 3521.53
52-week low 3412.30
50-day moving average 3493.40
200-day moving average 3466.52

Share statistics

Avg vol (3-month) 38.37k
Avg vol (10-day) 38.73k
Shares outstanding 5258.64M
Implied shares outstanding 6N/A
Float 8232.05M
% held by insiders 10.20%
% held by institutions 192.14%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 35.92
Trailing annual dividend yield 31.14%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 3.49%
Operating margin (ttm)5.64%

Management effectiveness

Return on assets (ttm)5.84%
Return on equity (ttm)15.82%

Income statement

Revenue (ttm)171.34B
Revenue per share (ttm)726.33
Quarterly revenue growth (yoy)6.80%
Gross profit (ttm)N/A
EBITDA 10.95B
Net income avi to common (ttm)5.99B
Diluted EPS (ttm)25.40
Quarterly earnings growth (yoy)-1.00%

Balance sheet

Total cash (mrq)36.37B
Total cash per share (mrq)156.31
Total debt (mrq)25.97B
Total debt/equity (mrq)65.90%
Current ratio (mrq)1.44
Book value per share (mrq)168.64

Cash flow statement

Operating cash flow (ttm)8.06B
Levered free cash flow (ttm)3B